Human-human hybridomas for solid tumors

Details Human-human hybridomas for solid tumors Human-human hybridomas for solid tumors

C - Chemistry, Metallurgy

12

N

167/37, 195/1.10

C12N 5/00 (2006.01) A61K 39/395 (2006.01) C12N 15/00 (2006.01) C12P 21/00 (2006.01) G01N 33/50 (2006.01) G01N 33/53 (2006.01) G01N 33/577 (2006.01)

Patent

CA 1247538

HUMAN-HUMAN HYBRIDOMAS FOR CERVICAL CARCINOMAS ABSTRACT OF THE DISCLOSURE Novel hybridomas, human monoclonal antibodies, and their uses are provided. Specifically CLNH5 is a human-human hybridoma which secretes IgM monoclonal antibo- dies specific for solid tumors. The monoclonal antibodies can find use in therapy and diagnoses, both in vitro and in vitro. The hybridomas CLNH5 and CLNH11 were deposited at the A.T.C.C. for patent purposes on January 28, 1983 and May 20, 1983 given A.T.C.C. Accession Nos. HB8206 and HB8207, respectively.

428517

Affiliated with

Also associated with

Rating

Human-human hybridomas for solid tumors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Human-human hybridomas for solid tumors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Human-human hybridomas for solid tumors will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1330064